Dermal Fillers: Materials, Realistic Results and Important Risks

Dermal fillers can restore volume or soften selected contours, but they do not relax muscles, and they are not all reversible. The material, exact product, treatment area and your medical history affect both the likely result and the risks. Most fillers are absorbed over time; some remain in the body. Even temporary fillers can cause lasting complications. Understanding those distinctions, asking about product-specific approval and knowing how to obtain urgent care are more useful than treating filler as a simple, easily undone cosmetic purchase.

1. What Can Dermal Fillers Actually Change?

Dermal fillers are injectable medical devices placed into tissue to create a fuller or smoother appearance. Depending on the product and its approved use, they can address selected facial folds, volume loss, contour deficiencies or recessed scars. Some products also have approved uses on the backs of the hands. These are different goals, so a product suitable for one concern is not automatically suitable for another.

Fillers work differently from botulinum toxin, an injectable drug that temporarily reduces muscle activity by blocking nerve signals. Filler adds material to tissue; botulinum toxin reduces the contraction that contributes to certain expression lines. A consultation should establish whether your concern relates mainly to volume, muscle movement, skin looseness or another feature before discussing treatment.

Realistic results depend on the underlying tissue structure and the type and amount of filler used. Fillers cannot reproduce the tissue repositioning achieved by a facelift or other lifting surgery. They also do not guarantee symmetry, a particular appearance or satisfaction. Choosing no treatment remains a reasonable option.

2. The Main Filler Materials and Their Limits

The distinction between temporary and permanent describes whether the material is absorbed. It does not tell you whether removal will be straightforward, how long every individual result will last or whether a complication can be reversed.

2.1 Temporary Does Not Mean Short-Lived or Easily Removed

Absorbable fillers do not all behave alike. HA gels bind water and provide a filling effect. PLLA effects become more apparent over time rather than representing an immediately finished result. The expected duration varies with the material, product and treatment area, so ask about the specific proposal rather than relying on a general claim about how long fillers last.

If maintaining the change would require further treatment, include that possibility in your decision. A longer-lasting effect may be appealing, but it also deserves careful discussion when you are uncertain about the appearance you want.

2.2 Permanent Describes the Material, Not a Guaranteed Appearance

PMMA microspheres are not absorbed by the body. This makes removal considerations especially important before treatment. Permanence does not guarantee a satisfactory result or freedom from later problems. Ask why a nonabsorbable product is being proposed and what options would remain if you developed a complication or disliked the outcome.

3. Can Dermal Fillers Be Dissolved?

Some HA fillers can be reduced using hyaluronidase, an enzyme that breaks down hyaluronic acid. This does not make all fillers reversible. CaHA, PLLA and PMMA do not have the same specific reversal option.

In its briefing for the August 13, 2025 dermal filler advisory panel meeting, the FDA described off-label hyaluronidase use as a clinically accepted method for removing HA filler. It also stated that hyaluronidase had not been FDA-approved for filler-related uses. Clinical use and regulatory approval are separate questions.

Dissolving should not be presented as risk-free. The FDA briefing discusses reported swelling, burning, redness, excessive volume loss and lack of effect following hyaluronidase use. Such reports identify concerns but cannot establish how frequently they occur. Removal procedures have their own risks, and a safe, reliable treatment for filler-related blindness applicable to all fillers has not been established.

Before consenting, ask what reduction or removal could realistically achieve for the proposed material. Do not accept “we can always dissolve it” as a complete explanation. Assessment and treatment of an unwanted result belong with a qualified clinician, not a home reversal attempt.

4. What Does FDA Approval Mean for Your Treatment?

In the United States, FDA approval is specific to the product, indication and age group. An indication is the particular use for which a product has been approved. A brand name or the phrase “FDA-approved filler” does not establish approval for every facial area or every patient.

Ask to see the patient labeling for the exact product. Confirm the proposed treatment site, intended correction and applicable age requirements. The FDA describes approved filler uses in adults aged 22 and older, but the actual product labeling should guide the discussion.

Regulatory summaries are not always equally detailed. For example, the FDA consumer guide lists under-eye hollows among approved uses, while another general FDA page retains broader wording recommending against injections around the eyes. This is a reason to check current product-specific labeling rather than infer that all products are approved, or unapproved, for an entire region.

Off-label use means use outside the approved labeling. It is not automatically interchangeable with a regulatory prohibition. Federal law preserves a practitioner's authority to use a legally marketed device within a legitimate clinical relationship, subject to applicable restrictions. That does not turn an off-label use into an FDA-approved one or establish its suitability for you. Ask what evidence supports the proposal and what uncertainty remains.

5. Swelling, Lumps and Delayed Problems

Bruising, swelling, redness, tenderness and pain are recognized early effects. Many resolve over days to weeks, but that broad pattern is not a deadline for recovery or reassurance about a particular symptom. Early swelling can also complicate judging the cosmetic result.

Other possible problems include asymmetry, undercorrection, overcorrection, infection and filler that can be felt beneath the skin. Nodules are raised lumps in or under the skin. Some lumps involve an inflammatory reaction, and some can persist or require further treatment.

Problems are not limited to the appointment or the first few days. The FDA notes that adverse effects can emerge weeks, months or years after injection. New swelling or lumps deserve assessment even if the original treatment seemed uneventful. Do not assume a delayed lump is harmless simply because the filler was described as temporary.

5.1 Vascular Occlusion and Rare Serious Harm

Vascular occlusion means blockage of a blood vessel. If filler accidentally enters a vessel, it can interrupt blood flow. The consequences depend on the tissue affected and can include necrosis, meaning tissue death, as well as wounds and scarring. Vision impairment, blindness and stroke have also been reported.

These serious complications are uncommon, but they may be permanent. Appropriate training and preparation matter; they do not justify promising zero risk. A provider should explain the risks of the proposed site and have an established plan for recognizing complications and arranging immediate care.

6. Symptoms That Need Immediate Clinical Attention

Seek immediate medical attention for unusual pain, vision changes, or white, gray or blue skin near the injection site during or shortly after treatment. Sudden difficulty speaking, facial drooping, weakness, confusion or other stroke symptoms also require emergency care. A severe allergic reaction requires immediate emergency assistance.

For vision changes, stroke symptoms or a severe allergic reaction, call 911 in the United States. Do not wait for a routine follow-up or an online reply. Tell the emergency team that you recently received dermal filler and, if known, which product was used and where.

This is not a complete symptom checklist. Contact the treating team promptly about worsening swelling, new or persistent lumps, redness or drainage, and seek urgent assessment if symptoms are severe or rapidly worsening. Written aftercare information should make clear who to contact and how to obtain help outside clinic hours.

7. Provider-Safety Questions Worth Asking

The FDA recommends a licensed health care provider trained in filler injection, with experience in dermatology or plastic surgery. Ask about relevant experience with the proposed product and treatment area, not simply how many cosmetic appointments the practice performs. Verify professional licensure through the appropriate state licensing board.

• What concern are we treating, and what change is realistic?
• What exact product and material would you use, and why?
• Is this use approved for this product, site and age group?
• What complications could occur here, including blood-vessel injury?
• What is your plan if a complication occurs during or after the appointment?
• Who provides follow-up, and who can assess urgent concerns after hours?
• What would reduction or removal involve, and what might remain unresolved?

Avoid self-injection, products sold directly to the public and needle-free filler pens. The FDA warns that directly sold products may be counterfeit or contaminated and has not approved needle-free devices for filler injection.

7.1 Share Your History and Keep Treatment Records

Discuss medical conditions, allergies, medications, supplements, previous filler and other facial procedures. Tell the clinician about active skin inflammation or infection. Some products contain local anesthetic or animal-derived ingredients, so the exact formulation matters. Pregnancy and breastfeeding also require discussion because the FDA states that safety in these circumstances is unknown.

Ask for a copy of your treatment record, including the date, exact product, material, amount used and treated areas. Request available batch or lot details and keep the patient information supplied. Bring previous records to future consultations, including if you change providers. Knowing what was placed is particularly relevant when discussing removal.

8. Plan Follow-Up Before Deciding

Before treatment, agree on how the result will be reviewed and how concerns will be assessed. Ask what the proposed product's expected course looks like, what changes should prompt contact and whether further appointments could be needed. A follow-up arrangement should cover both appearance-related concerns and medical complications.

Alternatives depend on the concern. Muscle-related lines may call for a different discussion from volume loss; substantial tissue looseness may not be addressed adequately with filler. Surgical options, fat grafting or no treatment can be discussed when relevant, but they have different limitations and risks.

The central decision is not simply whether dermal fillers “work.” It is whether a specific product offers a worthwhile change for your goal, with risks and removal limits you understand. Individual clinical assessment is necessary to answer that question. You should have time to consider the information without pressure to proceed.